These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10863658)

  • 1. Growth and respiratory health in adolescence of the extremely low-birth weight survivor.
    Doyle LW
    Clin Perinatol; 2000 Jun; 27(2):421-32. PubMed ID: 10863658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992.
    Doyle LW;
    Pediatr Pulmonol; 2006 Jun; 41(6):570-6. PubMed ID: 16617453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.
    Friedman CA; Menchaca RC; Baker MC; Rivas CK; Laberge RN; Rios EH; Haider SH; Romero EJ; Eason EB; Fraley JK; Woldesenbet M
    Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchopulmonary dysplasia].
    Clément A
    Rev Mal Respir; 1996 Jul; 13(3):243-9. PubMed ID: 8765916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early changes in respiratory compliance and resistance during the development of bronchopulmonary dysplasia in the era of surfactant therapy.
    Lui K; Lloyd J; Ang E; Rynn M; Gupta JM
    Pediatr Pulmonol; 2000 Oct; 30(4):282-90. PubMed ID: 11015127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical growth and current health status of infants who were of extremely low birth weight and controls at adolescence.
    Saigal S; Stoskopf BL; Streiner DL; Burrows E
    Pediatrics; 2001 Aug; 108(2):407-15. PubMed ID: 11483807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremely low birthweight infants: issues related to growth.
    Carroll J; Slobodzian R; Steward DK
    MCN Am J Matern Child Nurs; 2005; 30(5):312-8; quiz 319-20. PubMed ID: 16132008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997.
    Hacking DF; Gibson AM; Robertson C; Doyle LW;
    Pediatr Pulmonol; 2013 May; 48(5):449-55. PubMed ID: 22826206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.
    Kennedy KA; Cotten CM; Watterberg KL; Carlo WA
    Semin Perinatol; 2016 Oct; 40(6):348-355. PubMed ID: 27742002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life at age 18 years after extremely preterm birth in the post-surfactant era.
    Roberts G; Burnett AC; Lee KJ; Cheong J; Wood SJ; Anderson PJ; Doyle LW;
    J Pediatr; 2013 Oct; 163(4):1008-13.e1. PubMed ID: 23885966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and adrenal androgen status at 7 years in very low birth weight survivors with and without bronchopulmonary dysplasia.
    Korhonen P; Hyödynmaa E; Lenko HL; Tammela O
    Arch Dis Child; 2004 Apr; 89(4):320-4. PubMed ID: 15033838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-childhood lung function in a cohort of children with "new bronchopulmonary dysplasia".
    Fortuna M; Carraro S; Temporin E; Berardi M; Zanconato S; Salvadori S; Lago P; Frigo AC; Filippone M; Baraldi E
    Pediatr Pulmonol; 2016 Oct; 51(10):1057-1064. PubMed ID: 27077215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
    Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
    J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic outcome for intensive care of infants of birthweight 500-999 g born in Victoria in the post surfactant era. The Victorian Infant Collaborative Study Group.
    J Paediatr Child Health; 1997 Jun; 33(3):202-8. PubMed ID: 9259293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.